NCT03045965Active, not recruiting
Hysterectomy and OPPortunistic SAlpingectomy
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
HOPPSA is a register based randomized controlled trial (R-RCT), with the objective to examine if opportunistic salpingectomy compared with no salpingectomy, at the time of hysterectomy for a benign reason * has no increased risk of complications * has no negative side effects on ovarian function and subsequent cardiovascular disease or incidence of fractures * implies reduced risk of subsequent ovarian cancer Randomization and follow-up will be conducted within national registers.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 4400 (estimated)
- First submitted
- 16 Jan 2017
- Start date
- 1 Jun 2017
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Göteborg University
- Diseases
- Ovarian cancer
- NCT number
- NCT03045965
What you commit to
- Study type: Interventional
- Planned participants: 4400
- From 1 Jun 2017 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous bilateral oophorectomy and/or salpingectomy
Other illness
- Planned oophorectomy and/or salpingectomy (for reasons such as already diagnosed adnexal tumor, known carrier of the breast cancer susceptibility gene (BRCA) 1/2 mutation or Lynch syndrome (hereditary nonpolyposis colorectal cancer))
Other
- Non-understanding of the oral or written study information
Who the study is looking for
- Planned hysterectomy for a benign reason
- Age \< 55 years at randomization
- Willing to be randomized
- Vaginal route may be included if the surgeon is confident with performing vaginal salpingectomy.
Age in the registry: 20 years to 54 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sahlgrenska University Hospital Coordinator of this site? Confirm its status | Gothenburg | Sweden | Unknown status |
Related publications
- Effect of opportunistic salpingectomy at hysterectomy on anti-Müllerian hormone: A substudy of a randomized trial.Acta Obstet Gynecol Scand · 2026 · PMID 42157582
This page is information, not medical advice. Discuss any trial with your doctor.